Trial Condition(s):

Contraception

Return to fertility after discontinuation of contraception with Valette because of planned pregnancy

Bayer Identifier:

18863

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The main purpose of this observation was to acquire data on the return to fertility after discontinuation of Valette as an aspect of the tolerability and safety of this oral hormonal contraceptive (OC).

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
Inclusion Criteria:
                - Women with prescription of Valette (either as first OC or after switch from another OC) who discontinued the use of Valette because of wish to conceive

Trial Summary

Enrollment Goal
472
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Valette (Dienogest/EE30, BAY86-5038)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Germany

Status
Completed
 

Trial Design